CDKN2A and hepatocellular carcinoma: The results of prognostic analysis showed that HCC patients with higher expression of CDKN2A, DLAT, DLST, GLS, and PDHA1 had shorter OS, indicating that prognostic CRGs promoted the progression of HCC.